APA (7th ed.) Citation

Arana-Argaez, V., Martínez-García, E. A., Martin-Marquez, B., Muñoz-Valle, J., Medina-Contreras, O., Delgado-Rizo, V., . . . Mercado, M. V. (2009). S.128. Inhibitors of MAPK Pathway ERK1/2 or p38α/p38β Downregulate the Expression of SRP72 Autoantigen in Jurkat Cells Stimulated by IL-1β. Clinical Immunology, 131, S167. https://doi.org/10.1016/j.clim.2009.03.495

Chicago Style (17th ed.) Citation

Arana-Argaez, Victor, Erika A. Martínez-García, Beatriz Martin-Marquez, José Muñoz-Valle, Oscar Medina-Contreras, Vidal Delgado-Rizo, Minoru Satoh, and Mónica Vázquez-Del Mercado. "S.128. Inhibitors of MAPK Pathway ERK1/2 or P38α/p38β Downregulate the Expression of SRP72 Autoantigen in Jurkat Cells Stimulated by IL-1β." Clinical Immunology 131 (2009): S167. https://doi.org/10.1016/j.clim.2009.03.495.

MLA (9th ed.) Citation

Arana-Argaez, Victor, et al. "S.128. Inhibitors of MAPK Pathway ERK1/2 or P38α/p38β Downregulate the Expression of SRP72 Autoantigen in Jurkat Cells Stimulated by IL-1β." Clinical Immunology, vol. 131, 2009, p. S167, https://doi.org/10.1016/j.clim.2009.03.495.